William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 4,770 shares at $70.10 ($334K) on 2022-03-08, disclosed to the SEC on 2022-03-09.
Open-market sale of $334k NVCR by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.10 | 2,385 | $167K | 50.0% |
| 2 | $70.10 | 2,385 | $167K | 50.0% |
| Total | $70.10 avg | 4,770 | $334K | 100% |
| Filing → |
| ELAN | BUY | 2024-03-12 | $245K | — | Filing → |
| NVCR | SELL | 2022-08-03 | $117K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $297K | — | Filing → |